The University of Texas MD Anderson Cancer Center and two institutions at The University of Texas at Austin – the Oden Institute for Computational Engineering and Sciences and the Texas Advanced Computing Center (TACC) – today announced a new initiative to build a strong collaboration in Oncological Data and Computational Science.
The collaboration between the three UT System institutions, based in Houston and Austin, will...
In the first study to look at objective measures of sedentary behavior and cancer mortality, researchers from The University of Texas MD Anderson...
In patients with metastatic bladder cancer, a novel combination of biomarkers from baseline tumor tissues was predictive of improved clinical...
The University of Texas MD Anderson Cancer Center and Royal Philips today announced a collaboration to provide oncologists with evidence-based therapy and clinical trial guidance through Philips’ oncology informatics solutions and MD Anderson’s Precision Oncology Decision Support (PODS) system. This collaboration will allow physicians around the world to personalize therapy based on the patient’s genomic profile, with the aim of improving...
The University of Texas MD Anderson Cancer Center and Rakuten Medical, Inc. today announced a strategic alliance collaboration agreement to...
At MD Anderson, we are filled with anguish and deep sorrow over the senseless acts of racism and violence in our country and the tragic death...